Teodozyj Kolasa - Concepedia

Author

Teodozyj Kolasa

Abbott Fund

Also Known As

Kolasa, T., T KOLASA, T Kolasa, T. KOLASA, T. Kolasa, TEODOZYJ KOLASA, Teodozyj Kolasa

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Abbott (United States)Abbott (United Kingdom)University of Gdańsk University of Notre Dame

About

Teodozyj Kolasa is an author at Abbott Fund specializing in biochemistry, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	16	20	614
2	Natural Sciences	14	15	526
3	Medicine	12	15	466
4	Engineering	7	7	152
5	Health Sciences	2	2	31

Teodozyj Kolasa

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Synthesis of 4,5-Diaryl-1<i>H</i>-pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors Meena Patel, Randy L. Bell, S. Majest, The Journal of Organic Chemistry	2004	91
Reactions of .alpha.-hydroxy carbonyl compounds with azodicarboxylates and triphenylphosphine: synthesis of .alpha.-N-hydroxy amino acid derivatives Teodozyj Kolasa, Marvin J. Miller The Journal of Organic Chemistry Derivative (Chemistry)DerivativesBiochemistryNatural SciencesAltmetric Attention Score	1987	74
Structure−Activity Relationship of Triazafluorenone Derivatives as Potent and Selective mGluR1 Antagonists Guo Zhu Zheng, Pramila Bhatia, Jerome F. Daanen, Journal of Medicinal Chemistry Molecular PainPharmacotherapyTriazafluorenone DerivativesMolecular PharmacologyMedicinal Chemistry	2005	71
Synthesis of chiral zileuton, a potent and selective inhibitor of 5-lipoxygenase C.‐N. HSIAO, Teodozyj Kolasa Tetrahedron Letters Medicinal ChemistryHeterocyclicBiochemistryMedicineNatural Sciences	1992	54
Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A‐841720, a novel non‐competitive mGluR1 receptor antagonist Odile F. El-Kouhen, Sonya G. Lehto, Jia Bao Pan, British Journal of Pharmacology	2006	50
Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1 Masaki Nakane, Gin C. Hsieh, Loan Miller, International Journal of Impotence Research Nitric OxideMedicinePhysiologyNeuroscienceNervous System	2002	49
ABT-963 [2-(3,4-Difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2 H-pyridazin-3-one], A Highly Potent and Selective Disubstituted Pyridazinone Cyclooxgenase-2 Inhibitor Richard R. Harris, Lawrence A. Black, Sekhar Surapaneni, Journal of Pharmacology and Experimental Therapeutics	2004	45
Quantitative determination of hydroxylamine Teodozyj Kolasa, Waldemar Wardencki Talanta BiochemistryGas ChromatographyBioanalysisMass SpectrometryQuantitative Determination	1974	44
Preparation of (R)-(+)-N-[3-[5-[(4-Fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor. Carter D. Brooks, Andrew O. Stewart, James D. Ratajczyk, Journal of Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryAldehyde DehydrogenaseBiochemistryPharmacological Study	1995	44
Discovery of 3-Methyl-<i>N</i>-(1-oxy-3‘,4‘,5‘,6‘-tetrahydro-2‘<i>H</i>-[2,4‘-bipyridine]-1‘-ylmethyl)benzamide (ABT-670), an Orally Bioavailable Dopamine D<sub>4</sub> Agonist for the Treatment of Erectile Dysfunction Meena Patel, Teodozyj Kolasa, Kathleen H. Mortell, Journal of Medicinal Chemistry	2006	43

Page 1